Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
- Saturday, October 26, 2019, 7:17
- PR Newswire
- Add a comment
SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ — Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences. During the Festival of Biologics…
About the Author
admin has written 21636 stories on this site.